Post

New research · Rheumatology
medRxiv : the preprint server for health sciences · 4d
AI / informaticsmedRxiv : the preprint server for health sciences · 2026

A framework for human-artificial intelligence co-learning for disease activity labeling using electronic health records.

Zongxin Yang, Yuming Zhang, Zoe Love … Katherine P Liao
Read paper
RheumatologyAI / informatics

Human-AI co-learning reduces cost for disease activity labeling in electronic health records.

A framework for human-artificial intelligence co-learning for disease activity labeling using electronic health records.

Zongxin Yang … Katherine P Liao
medRxiv : the preprint server for health sciences · 2026
Purpose

To develop and evaluate a framework for human-AI interaction.

Methods

Using rheumatoid arthritis (rheumatoid arthritis) disease activity as the use- case, we studied a multi-institutional electronic health record-based rheumatoid arthritis cohort of 3,167 patients.

n = 3,167 patients
69%
Results
69%
reduced the estimated cost of identifying disease activity in patient records
n = 3,167 patients
More results

Expert reviewers labeled 626 notes from 273 patients; human-AI adjudication revised 127 (20%) of these initial labels and added 60 newly labeled notes, yielding a 686-note co-produced reference.

More results

Against this reference, the final agent's accuracy improved from a mean absolute error of 0.406 to 0.291 with co-learning, and its ambiguity flag agreed with expert ambiguity designations with 92.1% accuracy.

“
Conclusion · 1 of 2

Adopting a framework for human-AI co-learning, SHARE, improved the overall quality of gold-standard labels, identified ambiguous cases for further review, and supported accurate and standardized chart reviews of disease activity at a scale infeasible for manual review.

Conclusion · 2 of 2

SHARE's resource efficiency provides a transferable approach to incorporate complex phenotypes in real-world evidence studies.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Case Report
creatinine at 6.28 mg/dL
high level of a waste product, indicating severe kidney damage
Guideline
≥80% acceptance
most experts accepted the new treatment recommendations
Study
80% (4/5)
Four out of five patients with refractory systemic lupus erythematosus achieved remission.
Review
73%
patient-reported symptoms were used more often to define ongoing symptoms
Cohort Study
AUC of 0.804
how well the three-gene model identifies Dampness ZHENG
Cohort Study
OR 0.70
Odds of valve progression or new valve disease were similar with prophylaxis.
Study
AUC = 0.847
Good accuracy separating lupus patients from healthy people (higher AUC = better)
AI / Informatics
accuracy 0.731
the computer model correctly identified juvenile arthritis activity levels nearly three-quarters of the time